

                                                                   Exhibit 99.1

BOSTON SCIENTIFIC CORPORATION ANNOUNCES COMPLETION OF TARGET THERAPEUTICS, 
INC. MERGER

Natick, Mass. (April 8, 1997) Boston Scientific Corporation (NYSE:BSX) 
announced today that it has completed its acquisition of Target 
Therapeutics, Inc. (NASDAQ:TGET).

As a result of this merger, Target Therapeutics' stockholders will receive 
1.07 shares of Boston Scientific common stock in exchange for each share of 
Target Therapeutics common stock.

Boston Scientific is a worldwide developer, manufacturer and marketer of 
medical devices.  The Company's products are used in a broad range of 
Interventional medical specialties.



